A detailed history of Raleigh Capital Management Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Raleigh Capital Management Inc. holds 60,332 shares of PFE stock, worth $1.66 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares
60,332
Previous 61,828 2.42%
Holding current value
$1.66 Million
Previous $1.73 Million 0.98%
% of portfolio
0.69%
Previous 0.74%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$27.7 - $31.39 $41,439 - $46,959
-1,496 Reduced 2.42%
60,332 $1.75 Million
Q2 2024

Jul 31, 2024

SELL
$25.26 - $29.6 $225,521 - $264,268
-8,928 Reduced 12.62%
61,828 $1.73 Million
Q1 2024

May 13, 2024

BUY
$25.89 - $29.73 $162,459 - $186,555
6,275 Added 9.73%
70,756 $1.96 Million
Q4 2023

Feb 21, 2024

SELL
$26.13 - $33.94 $59,315 - $77,043
-2,270 Reduced 3.4%
64,481 $1.86 Million
Q3 2023

Dec 07, 2023

BUY
$32.09 - $37.51 $26,859 - $31,395
837 Added 1.27%
66,751 $2.21 Million
Q3 2023

Dec 06, 2023

BUY
$32.09 - $37.51 $20,762 - $24,268
647 Added 0.99%
65,914 $2.19 Million
Q2 2023

Jul 25, 2023

BUY
$36.12 - $41.79 $105,723 - $122,319
2,927 Added 4.7%
65,267 $2.39 Million
Q1 2023

May 22, 2023

BUY
$39.39 - $51.28 $464,802 - $605,104
11,800 Added 23.35%
62,340 $2.54 Million
Q4 2022

Feb 07, 2023

BUY
$41.75 - $54.5 $356,503 - $465,375
8,539 Added 20.33%
50,540 $2.59 Million
Q3 2022

Nov 09, 2022

BUY
$43.76 - $53.42 $298,880 - $364,858
6,830 Added 19.42%
42,001 $1.84 Million
Q2 2022

Aug 30, 2022

BUY
$46.53 - $55.17 $151,315 - $179,412
3,252 Added 10.19%
35,171 $1.84 Million
Q1 2022

May 12, 2022

BUY
$45.75 - $56.69 $1.44 Million - $1.79 Million
31,537 Added 8255.76%
31,919 $1.65 Million
Q4 2021

Feb 16, 2022

BUY
$41.32 - $61.25 $15,784 - $23,397
382 New
382 $23,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Raleigh Capital Management Inc. Portfolio

Follow Raleigh Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raleigh Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raleigh Capital Management Inc. with notifications on news.